Merck (MRK) Lists Cancer Genetics (CGIX) as KEYTRUDA National Reference Laboratory
Tweet Send to a Friend
Cancer Genetics, Inc. (Nasdaq: CGIX) announced that it is on Merck’s list of national reference laboratories offering the PD-L1 22C3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
